Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2021
Antidrug Antibodies and Drug Development: Challenges in the Immunotherapy EraBernard Doger de Spéville, Victor MorenoCurrent Opinion in Pharmacology|June 21, 2021
Adoptive cell therapy for solid tumors: Chimeric antigen receptor T cells and beyondVictor Moreno, Tatiana Hernandez, Maria de Miguel, et al.The Oncologist|April 11, 2026
Landscape of T-Cell Engagers in Solid TumorsEsther Garcia-Lorenzo, Miriam Dorta, Bernard Doger, et al.Cancers|July 27, 2024
Immunotherapy in Neuroendocrine Neoplasms: A Diamond to CutEsmeralda García-Torralba, Esther Garcia-Lorenzo, Bernard Doger, et al.The Lancet Regional Health. Europe|May 8, 2026
Evolution of bispecific and multispecific antibodies in cancer therapyElisa Fontana, Rafael Grochot, Nuria Kotecki, et al.Cancer|June 20, 2020
Increased vulnerability of clinical research units during the COVID-19 crisis and their protectionMaria de Miguel, Bernard Doger, Valentina Boni, et al.Cancer Chemotherapy and Pharmacology|March 25, 2022
Anti-drug antibodies in the current management of cancerMiguel Borregón, Katherine Martínez, Alba Ramos, et al.NPJ Precision Oncology|October 24, 2025
Prolonged survival in a patient with pbrm1 mutated metastatic cholangiocarcinoma receiving tazemetostatManuel Pedregal, Esther Cabañas Morafraile, Alberto Garrido, et al.Cancers|June 28, 2023
Genomic Mapping of Epidermal Growth Factor Receptor and Mesenchymal-Epithelial Transition-Up-Regulated Tumors Identifies Novel Therapeutic OpportunitiesLucía Paniagua-Herranz, Bernard Doger, Cristina Díaz-Tejeiro, et al.Cancer Treatment Reviews|May 2, 2024
Intratumoral therapies in head and neck squamous cell carcinoma: A systematic review and future perspectivesPablo Jiménez-Labaig, Antonio Rullan, Irene Braña, et al.Pageof 4